Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cardiac transplantation in transthyretin amyloid cardiomyopathy: outcomes from three decades of tertiary centre experience

Autor: Y Razvi, R Patel, A Ioannou, M U Rauf, A Masi, A Porcari, I Blakeney, N Kaza, H Lachmann, C Whelan, L Venneri, A Martinez-Naharro, P Hawkins, M Fontana, J D Gillmore

Publikováno v: European Heart Journal. 43

Background Transthyretin cardiac amyloidosis (ATTR-CM) is a progressive and fatal cardiomyopathy. Treatment options in patients with advanced heart failure are limited to cardiac transplantation (CT). Despite small case series demonstrating comparabl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3f994d1a78bc59bef7c55d295c3adde9
https://doi.org/10.1093/eurheartj/ehac544.1784

Zobrazit plný text záznamu

Size matters - redefining sex differences among patients with transthyretin amyloid cardiomyopathy – have we been wrong all along?

Autor: R Patel, A Ioannou, Y Razvi, L Chacko, L Venneri, A Martinez-Naharro, A Masi, H Lachmann, A Wechalekar, A Petrie, C Whelan, P Hawkins, J Gillmore, M Fontana

Publikováno v: European Heart Journal. 43

Background Transthyretin amyloid cardiomyopathy (ATTR-CM) is most often diagnosed in men (1–5). The few available studies suggest affected women have a more favourable cardiac phenotype (5–8), but remain unclear regarding differences in outcomes.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a4b9b62d7a528a53931084833165d256
https://doi.org/10.1093/eurheartj/ehac544.1760

Zobrazit plný text záznamu

A multi-modality, multi-parametric phenotyping study of transthyretin amyloid cardiomyopathy associated with the p.V142I TTR variant

Autor: Y Razvi, A Ioannou, L Chacko, R Patel, S Ganesananthan, N Kaza, I Blakeney, A Porcari, A Masi, L Venneri, M U Rauf, A Martinez-Naharro, P N Hawkins, M Fontana, J Gillmore

Publikováno v: European Heart Journal. 43

Introduction Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognised cause of heart failure. 3–4% of individuals of African descent carry a transthyretin gene mutation encoding the p.V142I variant, a powerful risk factor for de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::827f0156a26c1f576da7fc6df330026f
https://doi.org/10.1093/eurheartj/ehac544.1793

Zobrazit plný text záznamu

Changes in referral pathway and phenotypic status of patients diagnosed with ATTR cardiac amyloidosis during the past 20 years

Autor: A Ioannou, R K Patel, Y Razvi, A Porcari, L Venneri, F Bandera, A Masi, G E Williams, S O'Beara, S Ganesananthan, A Martinez-Naharro, L Chacko, P N Hawkins, J D Gillmore, M Fontana

Publikováno v: European Heart Journal. 43

Background Diagnostic and therapeutic advances have led to much increased awareness of transthyretin (ATTR) cardiac amyloidosis (CA). Purpose We sought to characterise the impact of this on referral practice, cardiac phenotype at diagnosis and specif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c5d0347b4ff4797f17827a9476f6b011
https://doi.org/10.1093/eurheartj/ehac544.1763

Zobrazit plný text záznamu

Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis

Autor: A Ioannou, R K Patel, Y Razvi, A Porcari, D Knight, A Martinez-Naharro, T Kotecha, L Venneri, L Chacko, P N Hawkins, J D Gillmore, M Fontana

Publikováno v: European Heart Journal. 43

Background Bone scintigraphy is extremely valuable when assessing patients with suspected cardiac amyloidosis (CA), but the clinical significance and associated phenotype of different degrees of myocardial tracer uptake across different types of amyl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c4640633bd13927aab215ac201e466f
https://doi.org/10.1093/eurheartj/ehac544.1762

Zobrazit plný text záznamu

Prognostic implications of clinical phenotype and severity of cardiac involvement in patients presenting with immunoglobulin light chain amyloidosis

Autor: A Porcari, A Masi, A Ioannou, R K Patel, Y Razvi, L Venneri, A Martinez-Naharro, G Sinagra, A Wechelakar, P N Hawkins, J D Gillmore, M Fontana

Publikováno v: European Heart Journal. 43

Background Patients with systemic immunoglobulin light chain (AL) amyloidosis may present with a wide array of signs and symptoms due to the multi-systemic organ involved. The presence of cardiac involvement is the key determinant of survival. Cardia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::11cf13c8cd5be155e54427ae086ff599
https://doi.org/10.1093/eurheartj/ehac544.1791

Zobrazit plný text záznamu

Myocardial ischaemia in cardiac amyloidosis: a change of perspective

Autor: A Ioannou, L Chacko, T Kotecha, R K Patel, Y Razvi, A Porcari, L Venneri, A Martinez-Naharro, D Knight, J Brown, P N Hawkins, J D Gillmore, M Fontana

Publikováno v: European Heart Journal. 43

Introduction Cardiac involvement is the main driver of clinical outcomes in systemic amyloidosis; however many clinical observations are not explained by the concept of replacement of the interstitium by amyloid material. Preliminary studies support

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c7b4497318e896a3a9ecabe26f010511
https://doi.org/10.1093/eurheartj/ehac544.1761

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání